- Home
- WAT
as 07-26-2024 4:00pm EST
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2023, Waters generated 57% from biopharmaceutical customers, 31% from industrial clients, and 12% from academic/government institutions.
Upcoming Earnings Alert:
Get ready for potential market movements as Waters Corporation WAT prepares to release earnings report on 31 Jul 2024.
| Founded: | 1958 | Country: | United States |
| Employees: | N/A | City: | MILFORD |
| Market Cap: | 17.9B | IPO Year: | 1995 |
| Target Price: | $298.00 | AVG Volume (30 days): | 405.6K |
| Analyst Decision: | Hold | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 10.18 | EPS Growth: | -11.40 |
| 52 Week Low/High: | $231.90 - $367.21 | Next Earning Date: | 07-31-2024 |
| Revenue: | $2,908,581,000 | Revenue Growth: | -1.94% |
| Revenue Growth (this year): | 1.14% | Revenue Growth (next year): | 6.25% |
Stock Insider Trading Activity of Waters Corporation (WAT)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| FEARON RICHARD H | WAT | Director | May 28 '24 | Buy | $332.90 | 1,000 | $332,900.00 | 1,653 | SEC Form 4 |
| KUEBLER CHRISTOPHER A | WAT | Director | May 15 '24 | Sell | $361.64 | 4,000 | $1,446,560.00 | 14,716 | SEC Form 4 |
| BADDOUR LINDA | WAT | Director | Mar 13 '24 | Sell | $355.54 | 500 | $177,770.00 | 2,250 | SEC Form 4 |
Latest Waters Corporation News
WAT Breaking Stock News: Dive into WAT Ticker-Specific Updates for Smart Investing
Zacks
2 days ago
Waters (WAT) to Report Q2 Earnings: What's in the Offing?
Argus Research
3 days ago
WAT: Lowering target price to $316.00
PR Newswire
3 days ago
Waters New Rapid Screening-DSC Enables Up to 24x Faster Thermal Stability Testing at Ultra-Low Sample Volumes for Antibody Drugs
Argus Research
10 days ago
WAT: Raising target price to $333.00
Argus Research
17 days ago
WAT: Lowering target price to $297.00
Argus Research
24 days ago
WAT: Lowering target price to $299.00
PR Newswire
24 days ago
Waters Corporation Schedules Second Quarter 2024 Earnings Conference Call
PR Newswire
2 months ago
Waters Sets New Standards for High Resolution Performance and Speed with Xevo MRT Mass Spectrometer
Compare WAT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "WAT Waters Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.